Cargando…
Insulators to Improve the Safety of Retroviral Vectors for HIV Gene Therapy
Retroviral vector gene therapy is a promising approach to treating HIV-1. However, integrated vectors are mutagens with the potential to dysregulate nearby genes and cause severe adverse side effects. Leukemia has already been a documented severe adverse event in gene therapy clinical trials for the...
Autores principales: | Browning, Diana L., Trobridge, Grant D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344246/ https://www.ncbi.nlm.nih.gov/pubmed/28424756 http://dx.doi.org/10.3390/biomedicines4010004 |
Ejemplares similares
-
Evidence for the in vivo safety of insulated foamy viral vectors
por: Browning, Diana L., et al.
Publicado: (2016) -
Identifying Cancer Driver Genes Using Replication-Incompetent Retroviral Vectors
por: Bii, Victor M., et al.
Publicado: (2016) -
Foamy Virus Vectors for HIV Gene Therapy
por: Olszko, Miles E., et al.
Publicado: (2013) -
Prospects for Foamy Viral Vector Anti-HIV Gene Therapy
por: Nalla, Arun K., et al.
Publicado: (2016) -
The use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene delivery
por: Anson, Donald S
Publicado: (2004)